Nicolas Burnett, MD
Radiation Oncology · Lexington, KYNPI 1417342999
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations.
Across 52 payments — averaging $34.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$363
- Elekta, Inc.$285
- AstraZeneca$199
- Progenics Pharmaceuticals, Inc.$170
- Telix Pharmaceuticals$120
- Novartis$81
- plus $569 from 21 others
What the payments were for
- Food & beverage$1,787100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 3 | $363 |
| Elekta, Inc. | 4 | $285 |
| AstraZeneca | 5 | $199 |
| Progenics Pharmaceuticals, Inc. | 3 | $170 |
| Telix Pharmaceuticals | 1 | $120 |
| Novartis | 3 | $81 |
| Merck | 4 | $70 |
| Amgen | 4 | $68 |
| Seagen Inc. | 3 | $45 |
| Incyte Corporation | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Acceleron Pharma, Inc. | 2 | $34 |
| Boston Scientific | 2 | $31 |
| Novocure Inc. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| AbbVie | 1 | $24 |
| Bayer | 1 | $22 |
| Array Biopharma Inc | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Beone Medicines USA, Inc. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Beigene USA, Inc. | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
| EMD Serono, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELEKTA MEDICAL LINEAR ACCELERATOR$515
- ILLUCCIX$241
- Clarity$129
- PYLARIFY$125
- TrueBeam$101
How this compares
$1,787 in reported general payments places this provider in the 75th percentile of 81 radiation oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 47 | $231 |
| Dexamethasone | 12 | $111 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Lexington
- Eddy YangLexington$20K
- Brian WilliamsLexington$5K
- Graham WarrenLexington$4K
- Aradhana KaushalLexington$2K
- Mark BernardLexington$2K
- Jonathan FeddockLexington$2K
- Laura DownesLexington$1K
- James KnightLexington$1K
- Marcus RandallLexington$1K
- Jacqueline MatarLexington$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.